Navigation Links
Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
Date:8/15/2008

ts 13,396,593 16,531,686

Property and equipment, net 112,694 127,788

Deposits 25,448 20,448

Total assets $13,534,735 $16,679,922

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:

Accounts payable $181,276 $219,866

Accrued expenses and other liabilities 558,867 83,419

Total current liabilities 740,143 303,285

Accrued expenses and other liabilities,

non-current 48,720 53,880

Total liabilities 788,863 357,165

Total stockholders' equity 12,745,872 16,322,757

Total liabilities and stockholders' equity $13,534,735 $16,679,922


'/>"/>
SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Controlling the size of nanoclusters: First step in making new catalysts
2. Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement
3. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
4. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
5. Experiments reveal unexpected activity of fuel cell catalysts
6. Using catalysts to stamp nanopatterns without ink
7. Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008
8. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
9. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
10. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
11. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...forpatientswithadvanced-stage,orrecurrentendometri...tCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(...edonendocrinetherapyandoncology,todayannouncedposi...otoxicpeptideconjugate,AEZS-108(formerlyAN-152),in...napersonalizedhealthcareapproach,thestudyselectedp...
(Date:11/24/2009)...tCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),thegloba...thatithassubmittedaMAAtotheEuropeanMedicinesAgency...ttherapyindevelopment,forthetreatmentofType1Gauche...aglucerasealfathathasbeensubmitted,withprevious,su...naglobalsupplyshortageofthecurrentlyapprovedandmar...
(Date:11/24/2009)...ire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )t...veChairman,willpresentatthe21stAnnualPiperJaffrayH...1,2009at10:00a.m.ET. ,, Toaccesstheliveandsubse...vestorRelationssectionofGenomicHealth,swebsiteat h...hewebsiteatleast15minutespriortothebeginningofthep...
(Date:11/24/2009)...s Customers with Partners Validated to Process and...ts , Ottawa, ON (PRWEB) N...der of products for biological sample collection, ... new global partner program. The program offers si...ommunity and is designed to help partners scale an...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...bcast Today at 10:00 CET, AMSTERDAM, February 20 ... a leader in the field of human gene therapy,today...hts - Successful IPO, raising gross proceeds of E...51.3 million at June 30, 2007 - U.S. FDA orphan d...ve results of Phase I/II in LPL type I deficiency ...
...ational Institute of Standards and Technology (NIS...nts of copper incorporated into zinc oxide (ZnO) n...t because copper plays a significantbut not well-u...properties of the nanowires. Previous experiments ...nc oxide is best known as a strong sunblock, cold ...
...Sigma-Aldrich(R) (Nasdaq:,SIAL) is pleased to anno...drich as Vice President of Global Marketing for th... be responsible for our strategic,and commercial m...the,identification, development and launch of inno...Bastian has over 15 years of international leaders...
Other Biology Technology:Amsterdam Molecular Therapeutics Reports Full Year Results 2007 2Amsterdam Molecular Therapeutics Reports Full Year Results 2007 3Amsterdam Molecular Therapeutics Reports Full Year Results 2007 4Amsterdam Molecular Therapeutics Reports Full Year Results 2007 5Amsterdam Molecular Therapeutics Reports Full Year Results 2007 6Amsterdam Molecular Therapeutics Reports Full Year Results 2007 7Chemists measure copper levels in zinc oxide nanowires 2Sigma-Aldrich Names Helge Bastian New VP of Global Marketing for Research Biotech 2
(Date:11/24/2009)... 24, 2009) New research on bacterial communities ...ls predictable temporal patterns, suggesting that ...for monitoring climate change in the polar regions...gs of the National Academy of Sciences Early Edit...ivers shifted synchronously over time, correlating...
(Date:11/23/2009)...mmunity-associated strain of the deadly superbug M... common antibioticsposes a far greater health thre...o hospitals, according to a study in the December ...new threat is easily picked up in fitness centers,...d the overall burden of MRSA within hospitals, the...
(Date:11/23/2009)...dlife Conservation Society says that western lowla...c of Congopart of the "mother lode" of more than 1...ncreasingly threatened by growing humans activity ... of the swamp forests adjacent to the southwest bo...eys confirmed that high densities of the great ape...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Be overweight and live longer 59643 1New findings on the formation of body pigment 59639 1University of the Basque Country study on proteins related to Alzheimers 10397 1University of the Basque Country study on proteins related to Alzheimers 10397 2
...eimer,s disease , Two thirds of all patients with ...s indicate that by 2010 our country will have more... a disease that gradually destroys brain cells, wi... with Alzheimer,s gradually declines. At first, me...apabilities also deteriorate as the disease progre...
...he bicentenary of the birth of eminent biologist t...ontract has been launched to conserve and protect ...iversity Belfast and the Northern Ireland Environm...al Heritage Research Partnership (NHRP) which was ...ing. , The project is being led by Quercus, Queen...
...wing word from Eurockot that launch of the Earth E... and October this year, ESA, CNES and the prime co...ed preparations for the last crucial steps before ...l Moisture and Ocean Salinity (SMOS) satellite has...es in Cannes, France since May last year awaiting ...
Other Biology News:New target for medicine to combat Alzheimer's: VIB scientists confirm protein's key role 2Darwin anniversary heralds new conservation research era for Northern Ireland 2ESA's water mission on track for launch 2
SUPERaseIn from Ambion
BD FACSAria Cell Sorting System from BD Biosciences - Immunocytometry Systems
EGTA from Research Organics, Inc.
...ate chemiluminescence efficiencies and the chemist...ve the added benefit that they require simple trig...ckground signal. This benefit has been exploited t...lications. These compounds can also be easily modi...
Biology Products: